HighGravityDataCurrent guidance
18 items
Eastman Chemical
Guidance from Eastman Chemical’s last 8 earnings releases. Every value links to its sentence in the filing. See something wrong? Tell us.
Releases tracked
8
Latest release
Jul 30, 2026
Data checked
Jul 30, 2026
What changed in the Jul 30, 2026 release
Each item compared with the same item in the previous release (Apr 30, 2026). Values in quotation marks are the company’s words.
New — first stated in this releaseRaised / Lowered / Narrowed / Widened — changed from the prior releaseRevised — wording changed, direction not determinableChanged — value changed; the comparison couldn’t be parsed to a directionReiterated — restated unchangedNot restated — stated before, absent nowRaised and lowered describe the number, not whether the change is favorable.
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| New | Additives & Functional Products earnings (sequential) | for Q3 FY2026 | — | “expected to decline modestly” | Filing ↗ |
| New | Adjusted diluted EPS | for Q3 FY2026 | — | “approach second-quarter 2026 EPS of $1.97” | Filing ↗ |
| New | Adjusted EPS | for Q3 FY2026 | — | “approach second-quarter 2026 EPS of $1.97” | Filing ↗ |
| New | Chemical Intermediates earnings (sequential) | for Q3 FY2026 | — | “expected to modestly decline” | Filing ↗ |
| New | Fibers earnings (sequential) | for Q3 FY2026 | — | “expect higher earnings in Fibers” | Filing ↗ |
| New | Advanced Materials EBIT (sequential) | for Q3 FY2026 | — | “expect EBIT to be higher” | Filing ↗ |
| New | Cost reduction, net of inflation | for FY2026 | — | “between $125 million and $150 million” | Filing ↗ |
| New | Operating cash flow | for FY2026 | — | “approach $900 million” | Filing ↗ |
| New | Working capital | for FY2026 | — | “expect to release working capital in the second half of 2026” | Filing ↗ |
| Reiterated | Earnings growth vs. prior year | for FY2026 | “significantly improve earnings in 2026 versus 2025” | “significantly improve earnings in 2026 versus 2025” | Filing ↗ |
| Reiterated | Capital expenditures | for FY2026 | “approximately $400 million” | “approximately $400 million” | Filing ↗ |
Show 1 item not restated in this release
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Not restated | Automotive end market demand | for FY2026 | “decline by low-single-digits” | — | Filing ↗ |
Current guidance
Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.
Current fiscal year
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Additives & Functional Products earnings (sequential) | “expected to decline modestly” | for Q3 FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Adjusted diluted EPS | “approach second-quarter 2026 EPS of $1.97” | for Q3 FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Adjusted EPS | “approach second-quarter 2026 EPS of $1.97” | for Q3 FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Chemical Intermediates earnings (sequential) | “expected to modestly decline” | for Q3 FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Earnings growth | “meaningfully improve earnings compared to 2025” | for FY2026 | Company-defined | Jan 29, 2026 | 1 | Filing ↗ |
| Earnings growth vs. prior year | “significantly improve earnings in 2026 versus 2025” | for FY2026 | Company-defined | Apr 30, 2026 | 2 | Filing ↗ |
| Fibers earnings (sequential) | “expect higher earnings in Fibers” | for Q3 FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Additional structural cost reduction, net of inflation | “approximately $100 million” | for FY2026 | Company-defined | Nov 3, 2025 | 1 | Filing ↗ |
| Advanced Materials EBIT (sequential) | “expect EBIT to be higher” | for Q3 FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Automotive end market demand | “decline by low-single-digits” | for FY2026 | Company-defined | Apr 30, 2026 | 1 | Filing ↗ |
| Capital expenditures | “approximately $400 million” | for FY2026 | Company-defined | Apr 30, 2026 | 2 | Filing ↗ |
| Cost reduction | “between $125 million and $150 million, net of inflation” | for FY2026 | Company-defined | Apr 30, 2026 | 1 | Filing ↗ |
| Cost reduction, net of inflation | “between $125 million and $150 million” | for FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Cost savings target, net of inflation | “between $125 million and $150 million” | for FY2026 | Company-defined | Apr 30, 2026 | 1 | Filing ↗ |
| Operating cash flow | “approach $900 million” | for FY2026 | GAAP-tied | Jul 30, 2026 | 1 | Filing ↗ |
| Operating cash flow | “approach 2025 levels” | for FY2026 | GAAP-tied | Jan 29, 2026 | 2 | Filing ↗ |
| Structural costs reduction | “approximately $100 million, net of inflation” | for FY2026 | Company-defined | Nov 3, 2025 | 1 | Filing ↗ |
| Working capital | “expect to release working capital in the second half of 2026” | for FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
How one item moved
Operating cash flow, for FY2025 — every statement across the year, each linked to its filing.
How your Specialty chemicals sector group guides
12 companies in Specialty chemicals. What they guide on, and who reported this season.
Most-guided metric families
This season’s releases
| RPM International | Oct 6, 2026 | 5 changes |
| Albemarle | Aug 5, 2026 | 24 changes |
| DuPont | Aug 4, 2026 | 11 changes |
| Cabot Corporation | Aug 3, 2026 | 4 changes |
| Eastman Chemical | Jul 30, 2026 | 9 changes |
| Huntsman | Jul 30, 2026 | 1 change |
| FMC Corporation | Jul 29, 2026 | 34 changes |
| Ashland | Jul 28, 2026 | 4 changes |
Get this for your own peer set — Peer Guidance Briefing, $3,000.
Full history
Every metric, every release, eight quarters — the complete record as one table.
| Metric | FY2026 | FY2025 | FY2024 | No period |
|---|---|---|---|---|
| Revenue from Kingsport methanolysis facility | — | 1 statement | — | — |
| Additives & Functional Products earnings (sequential) | 1 statement | — | — | — |
| Adjusted diluted EPS | 2 statements | 1 statement | — | — |
| Adjusted earnings per share | — | 3 statements | — | — |
| Adjusted EPS | 2 statements | 1 statement | — | — |
The full record for Eastman Chemical and its Specialty chemicals peers, delivered as a Peer Guidance Briefing — PDF and Excel, every value linked to its filing.
Filings
The 8 earnings releases this page is built from.
| Filed | Fiscal period | Accession | Guidance items | |
|---|---|---|---|---|
| Jul 30, 2026 | FY2026 Q2 | 0000915389-26-000138 | 12 | Open filing ↗ |
| Apr 30, 2026 | FY2026 Q1 | 0000915389-26-000094 | 11 | Open filing ↗ |
| Jan 29, 2026 | FY2025 Q4 | 0000915389-26-000006 | 3 | Open filing ↗ |
| Nov 3, 2025 | FY2025 Q3 | 0000915389-25-000176 | 8 | Open filing ↗ |
| Jul 31, 2025 | FY2025 Q2 | 0000915389-25-000152 | 10 | Open filing ↗ |
| Apr 24, 2025 | FY2025 Q1 | 0000915389-25-000099 | 5 | Open filing ↗ |
| Jan 30, 2025 | FY2024 Q4 | 0000915389-25-000007 | 5 | Open filing ↗ |
| Oct 31, 2024 | FY2024 Q3 | 0000915389-24-000225 | 2 | Open filing ↗ |
Values in quotation marks are the company’s words; the classification and filing links are HighGravityData’s. HighGravityData does not score or rank companies or give investment advice.
Report an error